ライフサイエンスコーパス: infectious mononucleosis

1 V infection, defined as flu-like symptoms or infectious mononucleosis).

2 al treatment of uncomplicated or complicated infectious mononucleosis.

3 the subsequent establishment of latency and infectious mononucleosis.

4 less IL-18 and Mig protein than tissues with infectious mononucleosis.

5 oratory utilization, and office diagnosis of infectious mononucleosis.

6 pathy, being diagnosed of Epstein-Barr virus infectious mononucleosis.

7 infection, with its associated high risk of infectious mononucleosis.

8 ctically all people who have not experienced infectious mononucleosis.

9 tion in adolescence was largely explained by infectious mononucleosis.

10 pathy, being diagnosed of Epstein-Barr virus infectious mononucleosis.

11 disease was reported in patients with acute infectious mononucleosis.

12 nonspecific symptoms, or have self-limiting infectious mononucleosis.

13 cells can limit EBV replication and prevent infectious mononucleosis.

14 nited Kingdom are seen only in patients with infectious mononucleosis.

15 orrelates with the incidence and severity of infectious mononucleosis.

16 nical and virologic evaluations during acute infectious mononucleosis.

17 namics of CD4(+) and CD8(+) T cells in acute infectious mononucleosis.

18 re than 90% of the human population, causing infectious mononucleosis(1), susceptibility to autoimmun

19 Of these, 77% had infectious mononucleosis, 12% had atypical symptoms, and

20 p for effect size=1.5 x 10(-19); I(2)=43%), infectious mononucleosis (2.17, 1.97-2.39; p=3.1 x 10(-5

21 of HD not associated with HIV (28%, 33%) and infectious mononucleosis (33%).

22 ein-Barr virus (EBV), the causative agent of infectious mononucleosis, a self-limiting lymphoprolifer

23 EBV-specific CD4(+) T cells in patients with infectious mononucleosis, a symptomatic manifestation of

24 plex phenotype manifested by severe or fatal infectious mononucleosis, acquired hypogammaglobulinemia

25 clear cells from Chinese children with acute infectious mononucleosis (AIM) and chronic active EBV in

26 blood of 10 individuals followed from acute infectious mononucleosis (AIM) into convalescence (CONV)

27 m cancer specimens was not observed in acute infectious mononucleosis (AIM) patients.

28 ls experiencing primary EBV infection (acute infectious mononucleosis [AIM]) and again 6 months later

29 h acute symptomatic primary infection (acute infectious mononucleosis [AIM]).

30 ablished risk factors (immunosuppression and infectious mononucleosis), allergic disease and eczema a

31 ells for at least a year after resolution of infectious mononucleosis, although the clone size is red

32 ) was present in 66% of patients (12/20 with infectious mononucleosis and 12/16 with tonsillar hyperp

33 samples from 20 American children with acute infectious mononucleosis and 16 Swiss children with chro

34 Though it is associated with infectious mononucleosis and approximately 200,000 cance

35 Epstein-Barr virus (EBV) causes infectious mononucleosis and can lead to lymphoprolifera

36 tic phase is also essential for EBV to cause infectious mononucleosis and cancers, including B lympho

37 s in most individuals who developed sporadic infectious mononucleosis and chronic EBV infection.

38 s both acute infections that result in acute infectious mononucleosis and chronic infections that res

39 are associated with prolonged fatigue after infectious mononucleosis and contrast these factors with

40 readily detected at presentation with acute infectious mononucleosis and declined rapidly thereafter

41 Epstein-Barr virus is the causative agent of infectious mononucleosis and infects approximately 90% o

42 EBV causes infectious mononucleosis and is associated with B cell l

43 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with B cell l

44 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with cancers

45 EBV causes infectious mononucleosis and is associated with certain

46 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with epitheli

47 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with malignan

48 human herpesvirus, is the causative agent of infectious mononucleosis and is associated with many car

49 stein-Barr virus (EBV) is the major cause of infectious mononucleosis and is associated with several

50 The ubiquitous EBV causes infectious mononucleosis and is associated with several

51 rus (EBV) is a human herpesvirus that causes infectious mononucleosis and is associated with several

52 n-Barr virus (EBV) is the causative agent of infectious mononucleosis and is associated with several

53 Barr virus (EBV) is the most common cause of infectious mononucleosis and is associated with the deve

54 s a ubiquitous human herpesvirus that causes infectious mononucleosis and is etiologically associated

55 by T cell surveillance, nevertheless causes infectious mononucleosis and is strongly linked to sever

56 s (EBV) poses numerous health risks, such as infectious mononucleosis and lymphoproliferative disorde

57 arr virus is a human herpesvirus that causes infectious mononucleosis and lymphoproliferative maligna

58 mmaherpesvirus EBV, which is associated with infectious mononucleosis and malignant tumors, harbors m

59 virus (EBV), which is the causative agent of infectious mononucleosis and multiple cancers(5), utiliz

60 The hazard ratios of interest for infectious mononucleosis and multiple sclerosis could be

61 ot statistically significant after excluding infectious mononucleosis and pneumonia.

62 people, we identified an association between infectious mononucleosis and PSC (odds ratio, 12; 95% co

63 milar between adolescents with CFS following infectious mononucleosis and recovered controls.

64 is a ubiquitous herpesvirus associated with infectious mononucleosis and several tumors.

65 hat LMP-1-del variants are frequent in acute infectious mononucleosis and tonsillar hyperplasia and i

66 e healthy donors with acute gastroenteritis, infectious mononucleosis, and Epstein-Barr virus/cytomeg

67 st that an EBV vaccine might help to prevent infectious mononucleosis, and further development of thi

68 A history of infectious mononucleosis, and high baseline EBV antibody

69 (EBV) infection is the most common cause of infectious mononucleosis, and persistent infection is as

70 n-Barr virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking showed the stronge

71 tellation should mirror the relative risk of infectious mononucleosis as a function of sibship conste

72 oid tissues diagnosed with acute EBV-induced infectious mononucleosis, as assessed by semiquantitativ

73 nfects B-cells and epithelial cells, causing infectious mononucleosis, as well as a number of cancers

74 r disease manifestations include fatal acute infectious mononucleosis, B-cell lymphoma, and progressi

75 ated Lyme disease who were misdiagnosed with infectious mononucleosis based on false-positive tests f

76 onstituted up to 5% of the CD8(+) T cells in infectious mononucleosis blood, the strongest latent Ag-

77 Siblings provide protection against infectious mononucleosis by occasionally preventing dela

78 Early, accurate diagnosis of infectious mononucleosis can help clinicians target trea

79 Infectious mononucleosis caused by Epstein-Barr virus (E

80 is nearly ubiquitous in humans, is causal to infectious mononucleosis, chronic active EBV infection,

81 S in lymphoid tissues with acute EBV-induced infectious mononucleosis compared to tissues with PTLD a

82 f a healthy 19-year-old female who developed infectious mononucleosis complicated by unilateral empye

83 CFS from adolescents who have recovered from infectious mononucleosis (controls), while certain cytok

84 virus-host interactions during self-limited infectious mononucleosis could explain how Epstein-Barr

85 m 1977 to 2018 for hospital contacts with an infectious mononucleosis diagnosis (n = 23 905) or a mul

86 When fulminant infectious mononucleosis (FIM) was excluded, there was n

87 e, affected patients often develop fulminant infectious mononucleosis (FIM), a life-threatening condi

88 haracterize its clinical presentation: fatal infectious mononucleosis (FIM), lymphomas, and immunoglo

89 en results in the clinical syndrome of acute infectious mononucleosis (glandular fever).

90 atal, clinical sequelae, including fulminant infectious mononucleosis, hemophagocytic lymphohistiocyt

91 d disease, developing severe and often fatal infectious mononucleosis, hemophagocytic lymphohistiocyt

92 viruses and the cause of pathologies such as infectious mononucleosis (IM) and certain cancers.

93 Up to 5% of university students develop infectious mononucleosis (IM) annually, and 9-12% meet c

94 Up to 5% of university students develop infectious mononucleosis (IM) annually, and 9-12% meet c

95 suggests a substantial genetic component in infectious mononucleosis (IM) etiology.

96 Infectious mononucleosis (IM) is an immunopathological d

97 Acute infectious mononucleosis (IM) is associated with altered

98 Infectious mononucleosis (IM) is suspected to be associa

99 Infrequently, EBV infection causes infectious mononucleosis (IM) or Burkitt lymphoma (BL).

100 table in the nonswitched memory pool both in infectious mononucleosis (IM) patients undergoing primar

101 red with those found in healthy individuals, infectious mononucleosis (IM) patients, and 12 PTLD pati

102 cell responses that, by T cell cloning from infectious mononucleosis (IM) patients, appear skewed to

103 l sequences has suggested that patients with infectious mononucleosis (IM) who are undergoing primary

104 Analysis of infectious mononucleosis (IM), a clinical syndrome that

105 f Epstein-Barr virus (EBV) and occurrence of infectious mononucleosis (IM), a cross-sectional study w

106 ein-Barr virus (EBV), the causative agent of infectious mononucleosis (IM), a disease associated with

107 rast, infection later in life often leads to infectious mononucleosis (IM), a febrile illness charact

108 omatic, delayed infection is associated with infectious mononucleosis (IM), a febrile illness in whic

109 ry infection is often asymptomatic or causes infectious mononucleosis (IM), a self-limiting lymphopro

110 tein-Barr virus and its acute manifestation, infectious mononucleosis (IM), are associated with an in

111 ary infection in adolescence can manifest as infectious mononucleosis (IM), as a fatal illness that m

112 + T cells is pathognomonic of EBV-associated infectious mononucleosis (IM), common in young adults.

113 In lymphoid tissues from patients with acute infectious mononucleosis (IM), interfollicular immunobla

114 his syndrome, which seems identical to human infectious mononucleosis (IM), persists for a further mo

115 pstein-Barr virus (EBV) infections may cause infectious mononucleosis (IM), whereas EBV reactivations

116 Controls included 8 cases of uncomplicated infectious mononucleosis (IM).

117 to EBV, and induces a syndrome comparable to infectious mononucleosis (IM).

118 rder distinct from self-limiting EBV-induced infectious mononucleosis (IM).

119 ng acute Epstein-Barr virus (EBV)-associated infectious mononucleosis (IM).

120 in the peripheral blood of 13 subjects with infectious mononucleosis (IM).

121 onuclear cells (PBMCs) from 26 patients with infectious mononucleosis (IM).

122 This consisted of the clinical syndrome of infectious mononucleosis in 7 children; in addition, 10

123 We present a paediatric case of infectious mononucleosis in a 13-year old, manifesting w

124 Infectious mononucleosis in childhood (hazard ratio [HR]

125 Infectious mononucleosis in early adulthood was also ass

126 d, analogous in many respects to EBV-induced infectious mononucleosis in humans.

127 d normal activities support the concept that infectious mononucleosis is most likely acquired by kiss

128 Infectious mononucleosis is the clinical manifestation o

129 ein-Barr virus (EBV), the causative agent of infectious mononucleosis, is a human herpesvirus associa

130 BV) establishes persistent infection, causes infectious mononucleosis, is a major trigger for multipl

131 rus (CAEBV) typically presents as persistent infectious mononucleosis-like disease and/or hemophagocy

132 Development of an infectious mononucleosis-like syndrome correlates with t

133 ishment of latency or the development of the infectious mononucleosis-like syndrome in infected mice.

134 ent, and both groups developed the prominent infectious mononucleosis-like syndrome that is character

135 Like EBV-infected humans with infectious mononucleosis, mice infected with the rodent

136 rus DNA in serum or plasma has been found in infectious mononucleosis, nasopharyngeal carcinoma, post

137 responsible for several diseases, including infectious mononucleosis, nonmalignant and malignant lym

138 Factors involved in determining whether infectious mononucleosis occurs after primary EBV infect

139 These focus on: (i) patients with infectious mononucleosis or its fatal equivalent, X-link

140 d a cohort of 250 primary-care patients with infectious mononucleosis or ordinary upper-respiratory-t

141 pheral blood B cells, isolated from the same infectious mononucleosis patients, to determine whether

142 ein-Barr virus (EBV), the causative agent of infectious mononucleosis, persistently infects over 90%

143 BV) is a human lymphocryptovirus that causes infectious mononucleosis, persists asymptomatically for

144 he magnitude of risk reduced after excluding infectious mononucleosis, pneumonia and CNS infection (h

145 statistically significant after exclusion of infectious mononucleosis, pneumonia, and CNS infection (

146 er this association is explained entirely by infectious mononucleosis, pneumonia, and CNS infections.

147 creased risk cannot be entirely explained by infectious mononucleosis, pneumonia, or CNS infections.

148 pidemiology that indicates that a history of infectious mononucleosis predisposes to HL.

149 68 causes a persistent infection, along with infectious mononucleosis, providing a model for studying

150 Three presented with EBV infectious mononucleosis requiring hospitalization, 1 ha

151 ells, obtained from donors with a history of infectious mononucleosis, showed diminished survival in

152 ause the risk of MS increases markedly after infectious mononucleosis (symptomatic primary EBV infect

153 ped EBV primary infections, including 2 with infectious mononucleosis syndrome.

154 unger siblings being more protective against infectious mononucleosis than older siblings.

155 met the criteria for CFS 6 months following infectious mononucleosis; the figure was 7% at 12 months

156 eukoplakia to nasopharyngeal carcinoma, from infectious mononucleosis to Hodgkin's disease (HD) and B

157 humans range from the fairly benign disease infectious mononucleosis to life-threatening cancer.

158 es ranging from asymptomatic viremia through infectious mononucleosis to posttransplant lymphoprolife

159 Epstein-Barr virus (EBV) causes infectious mononucleosis, triggers multiple sclerosis, a

160 Prior infectious mononucleosis was associated with increased o

161 A history of infectious mononucleosis was negatively associated with

162 nce and veteran-reported physician-diagnosed infectious mononucleosis were associated with CMI among

163 revealed that the majority of patients with infectious mononucleosis were infected with multiple str

164 = 0.0068) and carried a high risk of severe infectious mononucleosis when homozygous.

165 Unlike acute infectious mononucleosis, wherein EBV establishes lifelo